Thank You 2018 Boston Marathon Volunteers and Fans!


They say no one runs Boston alone. As the world’s oldest and most prestigious distance event the Boston Marathon terrain presents a tremendous challenge even on an ideal running day. This 122nd running was certainly not ideal and Mother Nature made the ups and downs of the hilly terrain mile after mile even more challenging …

Advertisements

Another PFO trial shows evidence of better outcomes for stroke patients following PFO closure


The findings support results of several trials and suggest that patients with a higher-risk #PFO are likely to benefit from a pfo closure device. According to findings presented at the 67th American College of Cardiology’s Annual Scientific Session,  patients who received a medical device to close a patent foramen ovale (PFO) after a stroke fared better …

Are cardiologists and neurologists finally working together to find consensus on the role of patent foramen ovale (PFO) closure after stroke?


The decision to close a PFO after a stroke should certainly only be made after extensive testing and collaboration by patients and clinicians working closely together.  From my experience being involved as a stroke patient advocate and following the stories of cryptogenic stroke patients with PFO over time, I've learned first hand that part of …

New American Academy of Neurology (AAN) Guidelines on PFO Closure in Cryptogenic Stroke are Discouraging


AAN Ruling Again on P values NOT Patient Values [In my opinion this is very discouraging news and more evidence to show there is still a great divide in how neurologists and cardiologists treat cryptogenic stroke with known PFO.] Despite the hard work of PFO patients (like myself) to make a difference by providing testimony and …

FDA Circulatory System Devices Panel Votes to Approve Amplatzer PFO Occluder


Post by David Dansereau,MSPT Know-Stroke.org On May 24,2016 I provided patient testimony at the Circulatory System Device Panel at the FDA along with Bray Patrick-Lake and Peggy Mahrt of the PFO Research Foundation and several other patients who also traveled to Washington DC to share their stories.   I wanted to share my FDA  testimony …